Asthma: Achievements and Questions in Front

author

  • Jamshid Salamzadeh Pharmaceutical Sciences Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
Abstract:

       Asthma, which is mainly distinguished by airway inflammation and bronchial hyper responsiveness, is known as one of the most common chronic diseases worldwide. It also is the most frequent chronic respiratory disorder amongst all age groups. On one side of the asthma story, there are massive investment of time, effort and money, a large number of pharmaceutical and academic research studies, health service modifications and revised guidelines. On the other side, there are unacceptably high, but mostly preventable, morbidity and mortality rates, socio-economic burdens and psychological problems due to asthma. A considerable proportion of doctor’s workload, hospital resources, health utilization costs, days off from school and work are caused by asthma. Our knowledge about this disorder and its complications is still on demand. There are significant questions regarding asthma and its pathophysiology which should be answered. National, regional and local initiatives are needed to be established to help health systems to overcome socio-economic burdens due to this disease. These could only be done if a clear picture of this respiratory disorder and its management achievements are available. This review article is an approach to present an image about asthma and its management based on the current understandings of the nature of this disorder.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

asthma: achievements and questions in front

asthma, which is mainly distinguished by airway inflammation and bronchial hyper responsiveness, is known as one of the most common chronic diseases worldwide. it also is the most frequent chronic respiratory disorder amongst all age groups. on one side of the asthma story, there are massive investment of time, effort and money, a large number of pharmaceutical and academic research studies, he...

full text

Cognitive dimensions: Achievements, new directions, and open questions

The Cognitive Dimensions framework has inspired research both more and less varied than expected. In this paper we revisit the original aims and briefly describe some subsequent research, to consider whether the original aims were too austere in rejecting knowledge-based dimensions; whether the dimensions can be shown to have real-world relevance; and whether their definitions can be improved, ...

full text

Professional achievements in medicine: too many unresolved questions.

From pre-enrollment assessments, through medical education and post-graduate training, medical schools are trying to educate and facilitate the development of their students so that they become exemplary experts in their future fields. Yet despite the long history of medical education, scientific research has failed to provide correlations between medical schools education processes and achieve...

full text

Sensor Data for Learning Support: Achievements, Open Questions & Opportunities

A recent trend in the field of learning analytics is to use sensor data about learners to support self-regulated learning. Combining personal, sensor based data with log data derived from a learning environment is a very promising approach, but also poses big challenges for the design of learner models and learner interaction methods, for the interpretation techniques of such data, and on appli...

full text

Omalizumab for severe allergic asthma: 7 years and open questions.

Anti-IgE treatment for severe allergic asthma has been available for more than seven years now. This treatment has clear clinical benefits and a good safety record. However, important questions concerning long-term dosing and treatment duration remain unanswered. This paper discusses the available information concerning the long-term use of omalizumab.

full text

[Allergic Rhinitis and its Impact on Asthma (ARIA) achievements in 10 years and future needs].

Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified AR as mild/moderate-severe and intermittent/persistent. This classification closely reflec...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 2

pages  63- 67

publication date 2005-04-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023